Last update 25 Feb 2026

CB-182804

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CB 182804
Target-
Action
inhibitors
Mechanism
Cell wall inhibitors
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Gram-Negative Bacterial Infections
Originator Organization
Biosource International, Inc.Biosource International, Inc.
Active Organization-
Inactive Organization
Cubist Pharmaceuticals LLCCubist Pharmaceuticals LLCBiosource International, Inc.Biosource International, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC54H86ClN17O13
InChIKeyOINMSSZOBLWDTB-LDPSCSCQSA-N
CAS Registry1231767-35-3

Related

100 Clinical Results associated with CB-182804
Login to view more data
100 Translational Medicine associated with CB-182804
Login to view more data
100 Patents (Medical) associated with CB-182804
Login to view more data
2
Literatures (Medical) associated with CB-182804
13 May 2021Journal of medicinal chemistryQ1 · MEDICINE
Total and Semisyntheses of Polymyxin Analogues with 2-Thr or 10-Thr Modifications to Decipher the Structure–Activity Relationship and Improve the Antibacterial Activity
Q1 · MEDICINE
01 Apr 2012Microbial drug resistance (Larchmont, N.Y.)Q3 · MEDICINE
Activity of Polymyxin B and the Novel Polymyxin Analogue CB-182,804 Against Contemporary Gram-Negative Pathogens in New York City
Q3 · MEDICINE
100 Deals associated with CB-182804
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gram-Negative Bacterial InfectionsPhase 1
United States
Cubist Pharmaceuticals LLCCubist Pharmaceuticals LLC
-
Gram-Negative Bacterial InfectionsPhase 1-
Biosource International, Inc.Biosource International, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free